These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3987021)

  • 1. Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment.
    Blum M
    Clin Exp Obstet Gynecol; 1985; 12(1-2):1-2. PubMed ID: 3987021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in glycosylated hemoglobin (HbA1c) in menopausal women treated with vaginal estrogen cream.
    Blum M; Pery J; Gelenter I
    Clin Exp Obstet Gynecol; 1985; 12(3-4):72-5. PubMed ID: 4064306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
    Chen J; Geng L; Song X; Li H; Giordan N; Liao Q
    J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience].
    Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E
    Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women.
    Mattsson LA; Cullberg G
    Acta Obstet Gynecol Scand; 1983; 62(5):397-401. PubMed ID: 6421083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause?
    Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogenic vaginal creams and calciuria in postmenopausal women].
    Blum M; Ariel J; Peri J
    Rev Fr Gynecol Obstet; 1984; 79(7-9):571-3. PubMed ID: 6098955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
    Barentsen R; van de Weijer PH; Schram JH
    Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transvaginal administration of estriol in postmenopausal urogynecological disorders].
    Di Stefano L; Patacchiola F; Moscarini M
    Minerva Ginecol; 1993 Nov; 45(11):551-6. PubMed ID: 8121603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspects.
    Kicovic PM; Cortes-Prieto J; Milojević S; Haspels AA; Aljinovic A
    Maturitas; 1980 Dec; 2(4):275-82. PubMed ID: 6785553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women.
    Mattsson LA; Cullberg G
    Acta Obstet Gynecol Scand; 1983; 62(5):393-6. PubMed ID: 6421082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P; Tagliaferri V; Amar ID; Cipolla C; Ingravalle F; Scambia G; Ricciardi W; Lanzone A
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen on serum lipid profile in early menopausal women.
    Itoi H; Minakami H; Iwasaki R; Sato I
    Maturitas; 2000 Oct; 36(3):217-22. PubMed ID: 11063904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy.
    Luisi M; Franchi F; Kicovic PM
    Maturitas; 1980 Dec; 2(4):311-9. PubMed ID: 6262604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 12 weeks of estriol cream on stress urinary incontinence post-menopause: A prospective multinational observational study.
    Te West NID; Harris K; Jeffrey S; de Nie I; Parkin K; Roovers JP; Moore KH
    Neurourol Urodyn; 2023 Apr; 42(4):799-806. PubMed ID: 36840920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Topical therapy of postmenopausal dyspareunia].
    Grio R; Mazza O; Cellura A; Zaccheo F; Giobbe C; Marchino GL; Malara D
    Minerva Ginecol; 1988 Dec; 40(12):695-7. PubMed ID: 3244441
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone loss during oestriol therapy in postmenopausal women.
    Lindsay R; Hart DM; Maclean A; Garwood J; Clark AC; Kraszewski A
    Maturitas; 1979 Jun; 1(4):279-85. PubMed ID: 399316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women.
    Iosif CS
    Arch Gynecol Obstet; 1992; 251(3):115-20. PubMed ID: 1605675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.